|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07K 14/755 | (2006.01) |
| A61K 38/00 | (2006.01) | ||
| A61K 38/37 | (2006.01) | ||
| A61K 47/60 | (2017.01) |
| (11) | Number of the document | 3130601 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16186901.1 |
| Date of filing the European patent application | 2005-11-14 | |
| (97) | Date of publication of the European application | 2017-02-15 |
| (45) | Date of publication and mention of the grant of the patent | 2020-07-15 |
| (46) | Date of publication of the claims translation | 2020-09-10 |
| (30) | Number | Date | Country code |
| 627277 P | 2004-11-12 | US |
| (72) |
PAN, Clark Q., US
MURPHY, John E., US
MEI, Baisong, US
STRAUSS, Jonathan S., US
TJANDRA, Hendri, US
CHEN, Jianmin, US
BARNETT, Thomas, US
TANG, Liang, US
WANG, Deqian, US
|
| (73) |
Bayer HealthCare LLC,
555 White Plains Road, Tarrytown, NY 10591,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Į vietą nukreipta FVIII modifikacija |
| SITE-DIRECTED MODIFICATION OF FVIII |
| Payment date | Validity (years) | Amount | |
| 2023-10-30 | 19 | 347.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2024-11-14 |